Prime Therapeutics

Exciting developments in the treatment of steroid-refractory acute graft-versus-host disease! Our March 2025 Expert Clinical Network Insights newsletter dives into the FDA-approved remestemcel-L-rknd (Ryoncil?) and its impact on pediatric patients. Get expert insights on its clinical trials, safety profile and more. Explore the details: https://bit.ly/43NT4xt

We are excited to attend ParetoHealth next week! With so much thought leadership and peer-to-peer learning on the horizon, we’re excited to connect. If you’ll be there, say hi to Prime’s own Bernadette Turowetz, Chris Mayer, Jennifer Child, Jody Murchland, Michelle Lutker, Lauren Verhoff, Barbie Smith, Matthew Patella, Jerry Homstad, J.D. Edwards, and Nick Fineman. Learn more about the event: https://bit.ly/40OYd59

It’s time for the 2025 Prime Therapeutics Report! Get a fresh perspective on specialty pharmacy management in our changing industry. Not only will you gain expert insights on gene therapy, GLP-1s and autoimmune management, you’ll also discover the value of integrated care, dive deeper into the world of precision oncology and get pipeline updates. Check it out today: https://bit.ly/41VTlMj

Join us at Prime as we revolutionize health care. Hear from Kimberly Rudolph, one of our expert recruiters, on why Prime is the ideal place for those eager to make a meaningful difference. Discover more: https://bit.ly/40LlANg

We’re excited to attend AMCP 2025! Our researchers will present posters and educational sessions all week. Visit booth 515 to connect! Learn more: https://bit.ly/4hAUgrr #AMCP2025

We’re improving the experience across health care, creating connections with our partners to provide a better, simpler experience for the people we serve. Whether it’s before a person gets care, when they’re at the doctor’s office or as they receive ongoing support, we’re focused on helping people navigate obstacles and improving their experience throughout their care journey. See how: https://bit.ly/3UFp7ud

In our latest Pharmacy Friends, key Prime research experts share how they’re advancing our purpose. Listen in to hear how their work helps Prime provide the same care we want for our loved ones as we seek to deliver better experiences and outcomes for everyone we serve. Join guest host Senior Public Relations Manager?Alex Cook?and guest experts Nicholas Friedlander, PharmD, senior health outcomes researcher; Scott Leslie, Ph.D., MPH, director of health outcomes; Kristin Brown-Gentry, MS, director of analytics; Jared P. Scripture, Ph.D., M.S., senior data scientist, Brooke Hunter, MS, data scientist principal; and Kristen Reimers, RPh, senior vice president, specialty clinical solutions, to hear directly from the researchers about their work and how they strive to provide the kind of care they would want for their loved ones through their work. Listen and subscribe: https://bit.ly/4ffsuQk

In the latest edition of Oncology Insights, Prime’s Abby Kim, PharmD, BCOP, shares about radiopharmaceuticals and how they could offer new options for people with cancer. Read more: https://bit.ly/3DzJBPG

Improving the pharmacy care experience is not just about lowering drug costs — it's about removing barriers to care. When medications are affordable, adherence improves, reducing the risk of dangerous and costly complications. Subscribe to Pharmacy Lens for exclusive access to expert opinions, in-depth articles and the latest trends in pharmacy!

Discover the latest insights from our Expert Clinical Network. This month's newsletter highlights the FDA approval of remestemcel-L-rknd (Ryoncil) for treating steroid-refractory acute graft-versus-host disease in pediatric patients. Learn about the efficacy, safety and patient experience with this groundbreaking mesenchymal stromal cell therapy: https://bit.ly/43NT4xt